<DOC>
	<DOCNO>NCT01089686</DOCNO>
	<brief_summary>This single center , multispecialty , randomize double blind placebo control feasibility clinical trial . The purpose evaluate safety , feasibility efficacy percutaneous transluminal angioplasty treat extracranial venous obstructive lesion , influence clinical outcome Multiple Sclerosis ( MS ) patient find chronic cerebrospinal venous insufficiency ( CCSVI ) .</brief_summary>
	<brief_title>Study To Evaluate Treating Chronic Cerebrospinal Venous Insufficiency ( CCSVI ) Multiple Sclerosis Patients</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Must 18 year old great less equal 65 year age Score 0 7 EDSS scale Diagnosis relapse remit secondary progressive Multiple Sclerosis neurologist confirm one independent study neurologist Presence great equal 50 percent stenosis extracranial vein determine venogram Informed consent sign patient Patient unwilling comply follow Patient pregnant Diagnosis primary progressive MS certify neurologist confirm one study neurologists Presence le 50 percent stenosis extracranial vein determine venogram Presence medical illness psychiatric condition opinion investigator may cause subject noncompliant protocol requirement Life expectancy less one year Lack mental capacity consent Creatinine level great 2.5 dialysis dependant Enrollment another clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Chronic Cerebrospinal Venous Insufficiency</keyword>
</DOC>